chrisvoncsefalvay/vaers-outcomes huggingface dataset:
shingles; Information has been received from a lawyer regarding a case in litigation concerning a female patient(pt) of unknown age. The pt's medical history, concurrent conditions and concomitant medications were not provided. In 2012, the pt was inoculated with zoster vaccine live(ZOSTAVAX)(dose, route of administration, anatomical location, lot#, expiration date were unknown), as prescribed and/or administered by a health care provider for the long-term prevention of shingles and zoster-related conditions. Subsequent to zoster vaccine live(ZOSTAVAX) inoculation, pt was treated for shingles. As a direct and proximate result of zoster vaccine live(ZOSTAVAX), pt has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future.
Patient from the nursing home arrived DOA. She was down for an unknown period of time no less than 70 minutes (another note said at least 20 min) before nursing home found her. When she was found at the nursing home the patient had no pulse and she had no pulse during any resuscitation efforts. Core temperature 95.9. She is developing rigors.
8 days post vaccination, pt showing signs of spread of vaccinia anteriorly and inferiorly to vaccination site, and to dorsum of forearm LUE. 2 sattelite lesions total.
A report received on 25Oct02 concerning a 33 year old vaccinee and approx 15 clinic staff members (demography unk) who were administered a Fluvirin injection by inappropriate route in error in Oct02. On an unk date in Oct02, the vaccinee and approx 15 staff members were administered Fluvirin with 1/2 inch needles. The reporter suspected that the staff members may have received the vaccine via a SC and not an IM route. No adverse events were reported. The reporter has assessed the relationship of the vaccines to the event unclassifiable. Update 1 13Dec02: An update report was received received from a health care professional on 13Dec02 concerning a 49 year old female vaccine who was administered Fluvirin SC on 08Oct02. On 08Oct02, the vaccinee was inadvertently administered Fluvirin SC. The outcome of the event was unk. No further information was provided. Ref: PJP200200657, PJP200200883, PJP200200882, PJP200200885, PJP200200889, PJP200200890.
Developed a red rash on both arms, trunk both legs and back.  She saw provider on Sept 30 who started her in Benadryl and cream for allergic reaction of unknown etiology.  She was seen again on Oct 1 because rash became very uncomfortabe.  She was given prednisone and referred to allergist.  Allergist did testing and determined the rash was due to flu vaccine she received on Sept 24th.  Rash is still present today Oct 19 2010.
Rash the developed on abdomen, spreading to lower back, spreading to shoulders. This rash has continued to present erupting in the same areas.  Has now spread to left leg, lower and then upper.  Have been seen multiple times in PCP office along with two visits to a dermatologist.  Given multiple creams, prednisone and antihistamines with no effect.  Had biopsy completed on one area.
Resident was administered 3rd dose d/t immunocompromising condition.  He was on hospice at the time of vaccination living in a nursing home.  He was observed to have a blood pressure lower than normal on 9/21/21 and hypoxia and tachycardia.  The resident received morphine.   He continued to decline and was provided comfort/end of life care.
Headache, Arthralgia, Fever, NauseaVomiting, 99, H/A, RIGHT EAR/NECK PAIN, CHILLS, NAUSEA Narrative:
This spontaneous report as received from a 58 year old female consumer reporting on herself with medical history of celiac disease, PRILOSEC allergy and REGLAN allergy. On 12-DEC-2012 the patient was vaccinated with PNEUMOVAX 23 (Lot # not reported) 0.5 ml, intramuscular. No other co suspects were reported. No concomitant therapy was reported. On 12-DEC-2012, the patient experienced stomach disorder, nausea and shallow breathing. The patient sought unspecified medical attention. The outcome of stomach disorder, nausea and shallow breathing was reported as not recovered/not resolved. Additional information has been requested.
Severe pain in bicep for 48 hrs not able to move arm. Committing fever flu like symptoms. No appetite. Cloudy thoughts.
A report was received from a health care professional on 10/3/03 concerning a vaccinee of unspecified demography who experienced a sore neck 2 to 3 days after receiving Fluvirin on an unknown date in 2003. On an unspecified date a vaccinee experienced a sore neck. It was not reported if the vaccinee had recovered at the time of the report. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Patient states left arm (at injection site) is swollen, red, large. Approximately 3" down and 5" across..she has no problem breathing.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE HYPOTENSION PULMONARY EMBOLISM, UNSPECIFIED.  2/19/2022 &  3/11/2022 -- RECURRENCE OF SAME SYMPTOMS
Patient presented for immunization of COVID19 Vaccine with no relevant history for contraindication. Approximately after 10 minutes of receiving the vaccine, the patient stated it felt like her throat was closing. She was flushed, felt warm in the face. She also had a red blotchy area on the left side of her neck. She was having difficulty swallowing. Epinephrine 0.3 mg IM was administered approximately at 1410. Patient was then transferred to the ED for treatment where she received diphenhydramine 25 mg IV push and methylprednisolone 125mg IV push at 1439. Patient's symptoms improved and was discharged at 1513.
PATIENT C/O ACHINESS, CHILLS, SWEATY, NAUSEA AND FEVERISH FEELING.  ONSET WAS ON THE EVENING SHE GOT THE VACCINE AND THE SYMPTOMS LASTED FOR 2 1/2 DAYS.  SHE DID NOT GO TO THE DOCTOR OR TAKE ANY MEDS FOR THE SYMPTOMS.  SHE DESCRIBES THE SYMPTOMS AS FEELING SIMILAR TO WHAT SHE FELT WHEN SHE HAD COVID-19 IN JUNE.  SHE DID NOT GET RE-TESTED.
On Tuesday, at approximately 12:00pm, I began getting severe head and body aches and extremely tired (which I know could be normal).  The next day (Wednesday 3/10), I woke up with hives on my left side of my face, my forehead, my neck, my chest and down my cleavage area of my breast.  I took Benadryl  and used hydrocortisone which did not help.  The next morning (Thursday, 3/11), I still have a small amount of hives on my neck and chest area only.
This spontaneous report was received from the registered nurse refers to an unknown number of patients of unknown age and gender. On an unknown date, the patient was vaccinated with RECOMBIVAX HB (dose, route and lot were not reported). On an unknown date, the patients received improperly stored   RECOMBIVAX HB. No adverse symptoms reported. At the time of the report the action was not reported. All telephone attempts to obtain follow-up information have been unsuccessful.  Additional information was received from a registered nurse concerning a neonate male patient. Patient's birth weight was 8 lb 3 oz with 2 siblings. Patient was vaccinated with RECOMBIVAX HB the same day that he was born (04-JUN-2014) at 14:22 PM. Lot number J012520; Exp. Date: 30-JAN-2016.  The vaccine storage temp dropped to 0-1 degrees on 18 different episodes between May 14th and July 21st (unspecified year) according to min/max. All recorded temps are within 2-8 degrees. Additional information is not expected since all follow ups requested to complete the case were received.
Expired Moderna was administered on 11/19/2021 lot# 046C21A. Patient was called back to the clinic and vital signs were taken and were WNL. Patient showed no s/s of any distress and when asked he states no s/s. Provider was notified and also Moderna manufacture and they will update with guidelines. Patient was released.
Pain at the injection site; This is a Spontaneous report received from a contactable consumer. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 intramuscular on 23Mar2021 as single dose for covid-19 immunisation.  The patient medical history was not reported.     The patient's concomitant medications were not reported.  They scheduled it at 17 days to get the second dose, which is 4 days before the recommended 21 days. The patient experienced pain at the injection site. The outcome of event was unknown.  No follow-up attempts are possible. No further information is expected. Information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021387360 same reporter/drug/event, different patient
Golf ball size rash formed around injection site.  Painful, pink in color, slightly raised, does not itch. Hydrocortisone cream reduced the color but nothing else. Have taken benadryl and waiting to see what that does. Will be taking advil and icing before bed.
Information has been received from a registered nurse concerning a 12 month old Asian male who on 04/03/01 was vaccinated with the first dose of MMR II SC in the left thigh. On 04/11/01, the pt experienced fever, cough x 2 days, rash to abdomen and conjunctivitis. The pt was treated with antibiotics, steroids and inhalers (not specified). Subsequently, the pt recovered. The registered nurse also reported on five other patients who had experiences following vaccination with MMR II (WAES01041191). Fever, cough x 2 days, rash to abdomen, and conjunctivitis were determined to be other important medical events. Additional info is not expected.
Janssen First dose and Pfizer Booster  Vaccinator offerred to vaccinate pt in the supine position.  Pt declined.  2mins post vaccination pt c/o dizziness.  Pt taken by w/c to sick bay and laid on cart for observation.given juice.  Dizziness resolved Vitals: 13:52 110/73, 60, 16, 100% O2 Sat -- > 14:01 115/69, 81, 16, 100% Pt stable and released from the vaccination site @14:03.  Pt ambulated independently w/ steady gait.
High fevers 3 days after the shot; Also headaches; Muscle aches; Chills; Night sweats; This case was reported by a consumer via interactive digital media and described the occurrence of fever in a patient who received Herpes zoster (Shingrix) for prophylaxis.  On an unknown date, the patient received Shingrix. On an unknown date, 3 days after receiving Shingrix, the patient experienced fever, headache, muscle pain, chills and night sweat. On an unknown date, the outcome of the fever, headache, muscle pain, chills and night sweat were unknown.   The reporter considered the fever, headache, muscle pain, chills and night sweat to be related to Shingrix.  Additional details were reported as follows: The reporter was the patient. The age at vaccination was not reported. The reporter asked was high fever 3 days after Shingrix was normal. On an unknown date, at an unknown time after receiving Shingrix, the patient also had headaches, muscle aches, chills and night sweats. The reporter stated that the vaccine was brutal.
patient was given double dose of Hep -B  vaccine.  Patient's Mother has been notified. Patient's Mother was told by this MA to watch for fever, swelling, redness, heat, irritability. If anything abnormal happens, contact this clinic, or go to the ED.
Patient describes intermittent left arm weakness that began about 10 days after receiving the first vaccine.  Reports seeing neurosurgery and was told it was likely brachioradialitis. It has since resolved.
Client complained of chest pressure. Pressure point applied for anxiety and symptoms improved. MD onsite released client in stable condition.
I broke out with a heat rash and hives on both sides of my neck and both wrists.; I broke out with a heat rash and hives on both sides of my neck and both wrists.; This is a spontaneous report from a contactable consumer (Patient). An adult non-pregnant female patient of an unspecified age (current age reported as 44-year-old) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: EW0168, and Expiration date: Unknown), via an unspecified route of administration, administered in left arm on an unspecified date in May2021 at 10:00 AM as dose 2, single for COVID-19 immunization. The patient medical history included gout, factor five Leiden syndrome, and calcium deposits. The patient received unspecified concomitant medications. The patient previously took VIT E [tocopherol] and experienced drug hypersensitivity. Previously the patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: EW0153, and Expiration date: Unknown), via an unspecified route of administration, administered in left arm on an unspecified date in Apr2021at 07:00 AM as dose 1, single for COVID-19 immunization. The patient received other vaccine on an unspecified date in May2021. No other vaccine in four weeks. The patient had no COVID prior vaccination. The patient was not tested for COVID post vaccination. The patient reported that, on 07May2021 03:00 AM, two days after receiving second COVID shot, "I broke out with a heat rash and hives on both sides of my neck and both wrists". It continued today, a month after her 2nd shot was administered. The patient visited her naturopath, tried to schedule an appointment. The patient took unspecified treatment for the events. The outcome of the events was reported as not resolved.  Follow-up attempts are completed. No further information is expected.
Pt presented to ER approx. 15min after onset of symptoms. Presented with visibly swollen tonsils, reported difficulty breathing, and hoarseness of voice. Was treated with 50mg Benadryl and discharged with improved symptoms.
Information has been received from a registered nurse referring to patient of unknown age and gender. The nurse reported that on unspecified dates the patient received improperly stored ROTATEQ oral liquid (Lot#, strength, dose and frequency were unspecified), orally and LIQUID PEDVAXHIB intramuscular injection (Lot#, strength, dose, frequency and route were unspecified), which were exposured to 33.2 Fahrenheit for 37 minutes. No adverse event was reported. Additional information has been requested.
6 inch diameter swollen red rash at injection site that is painful .  Tissue in affected area is firm, hot to touch and extremely itchy.  Also have sore throat and headache.
Pt said arm still very sore after 3 weeks, limited mobility. She stated she felt the injection was given too far back on the arm, not in the center.
sore, swollen lymph node at right collarbone A Fib episode for the 1st time in a couple months
it started as a small 1 inch red line and blew up into a huge itchy rash. extremely painful to touch. and very hot feeling on the skin like a sunburn. it grew in 12 hours to 5 inches across and about 4 inches down.
During a review of the Department of Health?s internal records, it was found that there might have been a possible temperature excursion with how the vaccine was stored with our mobile vendor.
Hearing loss in right ear; This study case was reported in a literature article and describes the occurrence of DEAFNESS UNILATERAL (Hearing loss in right ear) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.      Concurrent medical conditions included Meniere's disease (duration: 5+ years and status was active.).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DEAFNESS UNILATERAL (Hearing loss in right ear) (seriousness criterion medically significant). At the time of the report, DEAFNESS UNILATERAL (Hearing loss in right ear) outcome was unknown. Possible      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered DEAFNESS UNILATERAL (Hearing loss in right ear) to be possibly related.    Concomitant medications were not provided.   This study includes 18 patients with post-vaccination otologic symptoms.  For this patient, the days to onset of symptoms was between 23 days after each dose.  Most of the patients were still undergoing treatment, which may include oral, IT steroids, and/or antivirals. In all cases magnetic resonance imaging of the internal auditory canals was also ordered. The extent of hearing recovery and/or symptom resolution is currently unknown.  Company comment: This case concerns a 73-year-old male subject, with medical history of Meniere's disease, who experienced the unexpected serious event of DEAFNESS UNILATERAL. The event occurred approximately 2 days after the administration of both doses of Moderna COVID-19 Vaccine. The rechallenge was not applicable since no additional dosing will be given. The event was considered related to the vaccine per the reporter's assessment. Patient´s medical history of Meniere's disease, remains a confounder. The benefit-risk relationship of Moderna COVID-19 Vaccine is not affected by this report.   This case was linked to MOD-2021-337903, MOD-2021-337995, MOD-2021-337996, MOD-2021-337997, MOD-2021-337998, MOD-2021-337999, MOD-2021-338000, MOD-2021-338001, MOD-2021-338002, MOD-2021-338003, MOD-2021-338004, MOD-2021-338005, MOD-2021-338006, MOD-2021-338007, MOD-2021-338008, MOD-2021-338009, MOD-2021-338010 (Patient Link).; Sender's Comments: This case concerns a 73-year-old male subject, with medical history of Meniere's disease, who experienced the unexpected serious event of DEAFNESS UNILATERAL. The event occurred approximately 2 days after the administration of both doses of Moderna COVID-19 Vaccine. The rechallenge was not applicable since no additional dosing will be given. The event was considered related to the vaccine per the reporter's assessment. Patient´s medical history of Meniere's disease, remains a confounder. The benefit-risk relationship of Moderna COVID-19 Vaccine is not affected by this report.
Patient was seen on 06/14/23 for their 2 years well child visit.  Patient received a DTaP and Hep A in error.   They had just received the DTaP and Hep A at their 18 mo well child appt.  The vaccine given on 06/14/23 were done in error.  Patient didn't have an adverse reaction; however, they received an unnecessary DTaP and Hep A
Lymphadenopathy (swollen lymph node) for five days, starting five days after booster. Also related pain in neck and head.
Patient states hearing loss to left ear. Patient referred to Audiology. Prescribed Flonase.
On March 7, 2020 patient received her first HPV vaccine, she continued to be regular until January 2021 where her period started skipping every 3 month. Between the first HPV vaccine and January 1, 2021 she had a few inflammatory issues. She had a cellulitis on her finger 2 months after the vaccine, followed by in inflammation response on her lips and tongue. Patient received her second dose of the vaccine on March 13, 2021, at that point I mentioned to the doctor her periods were skipping and was told not to worry, it was normal at her age and we would only worry if it continued to skip or if she didn?t have her period for 6 months. She continued to skip her period having it every 3 months until January 2022, she skipped her period from January until October where it was induced by the endocrinologist.  During this period patient has had to seek treatment for a therapist due to panic attacks and self-harm. She has seen a cardiologist for heat palpations, a neurologist for Migraines, an endocrinologist for missed periods, an allergist to rule out the inflation was caused by an allergic reaction, an ophthalmologist for blurred and peripheral vision issues an OB/GYN to check her reproductive system and an adolescent doctor to try to piece it all together.
pain; in a lot of distress it sounds like due to pain and mental anguish; dizzy spells; nausea; hot flashes; depression; an interaction between a steroid shot of dexamethasone and Ketorolac that Patient received on 15May2021 and Moderna Covid-19 vaccine; crying; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (pain), ANXIETY (in a lot of distress it sounds like due to pain and mental anguish), DIZZINESS (dizzy spells), NAUSEA (nausea) and HOT FLUSH (hot flashes) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. ASKU) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.    Co-suspect products included non-company products DEXAMETHASONE for an unknown indication and KETOROLAC for an unknown indication.    Previously administered products included for Antidepressant therapy: LORAZEPAM and LEXAPRO. Past adverse reactions to the above products included No adverse event with LEXAPRO and LORAZEPAM.   On 13-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient started DEXAMETHASONE (unknown route) at an unspecified dose and KETOROLAC (unknown route) at an unspecified dose. On 15-May-2021, the patient experienced PAIN (pain), ANXIETY (in a lot of distress it sounds like due to pain and mental anguish), DIZZINESS (dizzy spells), NAUSEA (nausea), HOT FLUSH (hot flashes), DEPRESSION (depression) and DRUG INTERACTION (an interaction between a steroid shot of dexamethasone and Ketorolac that Patient received on 15May2021 and Moderna Covid-19 vaccine). In 2021, the patient experienced CRYING (crying). At the time of the report, PAIN (pain), ANXIETY (in a lot of distress it sounds like due to pain and mental anguish), DIZZINESS (dizzy spells), NAUSEA (nausea), HOT FLUSH (hot flashes), DEPRESSION (depression) and DRUG INTERACTION (an interaction between a steroid shot of dexamethasone and Ketorolac that Patient received on 15May2021 and Moderna Covid-19 vaccine) had not resolved and CRYING (crying) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was withdrawn on an unknown date.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  Two days after receiving the vaccine the patient went to the pain clinic for a shot of dexamethasone and ketorolac. The patient life has been turned upside down and was ruined. The patient never received her second dose of the Moderna Covid-19 vaccine because had such a bad experience due to what the patient said was an interaction between a steroid shot of dexamethasone and Ketorolac that patient received on 15May2021 and Moderna Covid-19 vaccine. Treatment medications were not reported.
Left upper extremity 3x4 cm red, nontender, nonfluctuant, full range of motion and no drainage.
Rash all over the body. Itchy. Taking Zyrtec for treatment. No outcomes yet.
Worsened depression and anxiety, I actually don?t think it is related to the vaccine, but answered for completeness sake.
Shrill crying x 4 hrs, 101 temp, inject site swelling to size of an egg (hard, hot to touch, pain).